PeptideDB

6-Hydroxykaempferol 3,6-diglucoside

CAS No.: 142674-16-6

6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation in
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description 6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
In vitro Four constituents, 6-hydroxykaempferol 3,6,7-tri-O-glucoside (1), 6-hydroxykaempferol 3-O-rutinoside-6-O-glucoside (2), 6-hydroxykaempferol 3,6-di-O-glucoside (6-Hydroxykaempferol 3,6-diglucoside,3), and syringin (4) were isolated from the flower of Carthamus tinctorius L. and were examined for the inhibitory effects on platelet aggregation. The platelet aggregation was monitored by a platelet aggregometer employing a laser-scattering method. The compounds were identified on the basis of NMR spectral data.
molecular weight 626.52
Molecular formula C27H30O17
CAS 142674-16-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Antiplatelet Aggregatory Effects of the Constituents Isolated from the Flower of Cartham.ua tinctoriusNatural Med., 2005, 59(5):241-4.